ArticleFrontline gastroenterology2016

Incidence of metachronous visible lesions in patients referred for radiofrequency ablation (RFA) therapy for early Barrett's neoplasia: a single-centre experience.

J Ortiz-Fernández-Sordo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.